MDS Logo

March 10, 2010 | Contact MDS

  • Our Company
  • Our Markets
  • For Investors
  • For Media
  • For Potential
    Employees
  • Focus on MDS Nordion

 

  • For Investors
    • Investor Overview
    • Stock Info
      • Stock Quote
      • Historical Price Lookup
      • Investment Calculator
      • Dividend Information
    • News & Events
      • News Releases
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
        • 2003
        • 2002
        • 2001
        • 2000
        • 1999
      • Calendar of Events
      • Webcasts & Presentations
    • Financial Information
      • Annual Reports
        • Archived Reports
      • Financial Results
      • Supplemental Information
      • SEDAR
      • EDGAR
    • Corporate Governance
      • Corporate Governance
        • 2009 Annual Report
        • Proxy Circular
        • Directors and Management
          • Board of Directors
          • Executive Management Team
        • Compensation of Directors
        • Board and Committee Charters
        • Guidelines & Practices
        • Disclosure Required by Section 303A.11 of NYSE
      • Global Business Practice Standards
    • Investor Resources
      • Risk Factors
      • Financial Summary
      • Analyst Coverage
      • General FAQs
      • Dividend Info
    • Investor Information
      • Investor Kit
      • Report Request Form
      • Subscribe to e-mail alerts
    • Investor Relations Contacts
    • Contact MDS
    • Focus on MDS Nordion
Home>

 

News Releases 2010

03-08-2010 MDS Inc. Completes Divestiture of MDS Pharma Services Early Stage Business
03-04-2010 MDS to Release First-Quarter 2010 Financial Results
02-19-2010 MDS Announces Substantial Issuer Bid
02-10-2010 MDS Announces Agreements to Divest MDS Pharma Services' Early Stage Business
02-05-2010 MDS Nordion's TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers
02-01-2010 MDS Inc. Announces Appointment of William D. Anderson as Chair of Board of Directors
02-01-2010 MDS Inc. Completes Divestiture of MDS Analytical Technologies
01-27-2010 MDS Receives U.S. Federal Trade Commission Provisional Regulatory Approval for Sale of MDS Analytical Technologies
01-26-2010 MDS Files 2009 Annual Reports
01-25-2010 MDS Announces Resolution of Litigation Related to the Sale of MDS Analytical Technologies
01-21-2010 MDS Reports Preliminary Fourth Quarter and Fiscal 2009 Financial Results
01-08-2010 MDS Appoints Steve West MDS Inc. Chief Executive Officer
01-07-2010 MDS to Release Fourth Quarter 2009 Financial Results

© 2009 – 2010  MDS Inc. All Rights Reserved    Home | Sitemap | Corporate Governance | Terms of Use | Privacy